Home » Expert Content » Webinars

EXPERT CONTENT

Downloadable expert content covering integrated, tailored solutions to accelerate your path to market.

VISIT OUR YOUTUBE CHANNEL

EXPERT CONTENT

Downloadable expert content covering integrated, tailored solutions to accelerate your path to market.

VISIT OUR YOUTUBE CHANNEL

BROWSE BY

TOPIC:






TYPE:



Continuous Processing In Biomanufacturing

Summary: As the biologics industry continues to grow, biopharmaceutical companies are evaluating continuous processing as a potential means to improve efficiencies. There are many factors to consider when determining whether continuous processing should be adopted, and if so, what adoption strategy should be used…

read more

Moving A Complex Protein From Development To Large-Scale Clinical Production

Summary: The number of more complex biopharmaceuticals in development continues to increase. These include molecules like virus-like particle vaccines, proteins that require cleavage, or other additional post-translational modifications not typically performed by CHO cells, and more recently, numerous different multi-specific antibody platforms…

read more

Accelerating Biologics And Biosimilar Development

Summary: Get to know how Catalent’s scientists have utilized ambr 15® as a micro-scale model for a synergistic clonal and process screen to identify the master cell bank candidates. Using this multi-layered approach, early in the development process significantly improves selection of top clones while shortening the overall timeline…

read more

Developing Site-Specifically Modified ADCs Using A Chemoenzymatic Approach

Summary: Antibody-drug conjugates (ADCs) have become de rigueur for pharmaceutical oncology drug development pipelines. There are more than 40 ADCs undergoing clinical trials and many more in preclinical development. This webinar hosted by Elsevier’s Drug Discovery Today presented novel protein modification platform and its application…

read more

Evolution Of Biomanufacturing Facilities

Summary: Advances in single-use bioreactor technologies offer rapid development pathways when combined with creative upstream process development strategies. When aggressive program timelines are required, the application of multiplexed conditions coupled with smart CMC decisions that maximize yields…

read more

Clinical Trial Supply Strategies For Biosimilar Studies

Summary: The use of biosimilars in clinical trials is on the rise. Often tightly controlled or in short supply, sourcing the necessary drugs can be challenging. Given the variability of biosimilars, studies using these products are particularly at risk for supply-related delay and cost overruns unless proactively managed from the beginning…

read more

Optimized Antibody Drug Conjugate Development

Summary: One of the current challenges with existing ADCs is the difficulty in creating conjugates with a uniform drug to antibody ratio and consistent payload placement on the antibody, both aspects which are paramount in creating consistent and predictable therapies…

read more
bars6